Skip to main content
  • Home
  • Media
  • News
  • Birgitta Stymne Göransson elected member of LEO Pharma’s Board of Directors

Birgitta Stymne Göransson elected member of LEO Pharma’s Board of Directors

BALLERUP, Denmark, November 14, 2019 – LEO Pharma A/S today announced that Birgitta Stymne Göransson has been elected member of the company’s Board of Directors.

Birgitta Stymne Göransson has worked as non-executive Boardmember, Chairman and Committee Chair of several boards and audit committees and has more than 25 years’ of experience in medtech and IT/tech as well as consulting, consumer retail and branded goods.

Birgitta Stymne Göransson’s current chairmanships include BCB Medical Oy and Industrifonden in Sweden as well as Chair of the Audit Committees of Elekta AB and Pandora AS. In her previous executive roles, she has among other worked as Industrial Advisor to Ratos AB, and held positions as Chief Executive at Memira Holding AB and Semantix Group AB.

Olivier Bohuon, Chairman of the Board of Directors at LEO Pharma A/S, says: “We are pleased to welcome Birgitta Stymne Göransson to the Board of Directors. With her broad industry insights and deep financial experience from both public and private companies,  she will play an important role in the realization of LEO Pharma’s  ambitious growth strategy.”

Birgitta Stymne Göransson holds an MBA from Harvard Business School, MA, USA as well as a M.Sc. in Chemical Engineering and Biotechnology from the Royal Institute of Technology in Sweden.

About LEO Pharma

LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, and today, the company offers a wide range of therapies for all disease severities. LEO Pharma is headquartered in Denmark with a global team of 5,800 people, serving millions of patients across the world. In 2021, the company generated net sales of DKK 9,957 million.

CONTACT US

Trine Juul Wengel

Global External Communication
Tel: +45 2073 2037